Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting

OBJECTIVE: This study tried to observe additional benefit of agomelatine (AGO) treatment for major depressive disorder (MDD) in routine practice. METHODS: Retrospective chart review (n = 63) was conducted for additional benefit of combination with or switching to AGO in MDD patients without full rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kyung Ho, Han, Tae Sun, Han, Changsu, Bahk, Won-Myong, Lee, Soo-Jung, Patkar, Ashwin A., Masand, Prakash S., Pae, Chi-Un
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335900/
https://www.ncbi.nlm.nih.gov/pubmed/37424426
http://dx.doi.org/10.9758/cpn.23.1060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335900/
https://www.ncbi.nlm.nih.gov/pubmed/37424426
http://dx.doi.org/10.9758/cpn.23.1060

Ejemplares similares